Figure 2From: Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomideFrequency of cytogenetic abnormalities by MC only, or by MC, FISH, and SNP-A. Compared to MC only (left), addition of FISH and SNP-A (right) improved the detection rate of chromosomal abnormalities dramatically from 21% to 67% in patients receiving LEN without del(5q) by MC (N = 42).Back to article page